🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsWhen to hold at a dose vs continue titrating — clinical decision framework

When to hold at a dose vs continue titrating — clinical decision framework

Dr.ObesityLA Sun, Mar 8, 2026 at 10:00 PM 7 replies 311 viewsPage 1 of 2
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Mar 8, 2026 at 11:25 PM#1

When to hold at a dose vs continue titrating — clinical decision framework

I've written this guide because I keep seeing the same questions come up about When to hold at a dose. Rather than repeating myself across threads, here's everything in one place.

Who this is for: Anyone interested in when to hold at a dose, whether you're a newcomer or looking to deepen your understanding.

1. Overview

When to hold at a dose is an important topic in the dosing & protocols space. Understanding the fundamentals will help you make more informed decisions and have better conversations with your healthcare provider.

2. What the evidence says

The clinical trial data is extensive. Multiple randomized controlled trials (STEP, SURMOUNT, SUSTAIN, SURPASS programs) have established clear efficacy and safety benchmarks. I'll reference specific data points throughout this guide.

3. Practical recommendations

  • Start with the basics — don't overcomplicate things early on
  • Track your own data systematically (weight, labs, side effects)
  • Consult your healthcare provider before making any changes
  • Use this community as a supplement to — not a replacement for — professional medical care

4. Common mistakes

The most common errors I see: rushing titration, inadequate protein intake, not getting baseline labs, and relying on anecdotal reports over clinical data.

This guide is educational. It does not constitute medical advice. Last updated March 2026.

— Dr.ObesityLA | Dosing & Protocols
27 19zoe_NC, Dr.ObesityLA, NurseKim_ATL and 24 others
Reply Quote Save Share Report
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Mar 8, 2026 at 11:42 PM#2

Dr.ObesityLA — wow. This community is amazing.

19 11KevinCompounds, TirzTom, TrialTracker_MD and 16 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Mar 8, 2026 at 11:59 PM#3

Thanks for sharing this, Dr.ObesityLA. A few questions about your When to hold at a experience:

  1. What dose are you currently on?
  2. How long before you noticed significant changes?
  3. Did your doctor have any specific recommendations about When to hold at?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

42 15marcus_mpls, DeniseRN_TPA, SandraNC_45 and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Mar 9, 2026 at 12:16 AM#4

Clinical perspective on When to hold at a dose vs continue:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

Last edited: Mar 9, 2026 at 5:16 AM
31 10Dr.PeteFamMed, claudia_zurich, nancy_portland and 28 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Mar 9, 2026 at 12:33 AM#5

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on When to hold at a dose vs.

To answer Dr.EndoIndy: yes, I am on compounded sema from a 503B pharmacy.

Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Last edited: Mar 9, 2026 at 1:33 AM
2 16jason_sac26, chris_chi24
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register